Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1160 - Hepatitis C testing for access to Telaprevir

Assessment No.

1160
Application NameHepatitis C testing for access to Telaprevir
Description Of Intervention-
Description Of Disease-
Disease GroupHepatitis
Disease sub GroupLiver
Intervention CategoryInvestigative
Intervention TypePathology
Intervention Sub TypeMolecular Genetics
Received31 March 2011
Stage 2 - Eligibility20 April 2011
Stage 3 - 1st PASC Expected: 6 - 7 July 2011
Stage 3 - Public CommentExpected release: 18 July 2011
Stage 3 - 2nd PASCExpected: 14 - 15 September 2011
Stage 4 - Submission of Evidence-
Stage 5 - ESC evaluation-
Stage 6 - MSAC Appraisal-
Stage 6 - MSAC advice-
Stage 7 - Noting by Minister
  • advice is not communicated to the Minister until the Minutes of the relevant meeting have been ratified by MSAC members (which may take several weeks)
  • the Minister needs time to properly consider MSAC's advice (and may choose to seek further policy advice from the department before noting the advice)
  • a Government decision to list a service supported by MSAC is taken in the context of other Government priorities: MSAC's support of an application for public funding does not oblige the Government to list the service on the MBS
-
Stage 8 - Implementation-

Page currency, Latest update: 07 November, 2014